Abstract:The isolated copper(II) complex [CuL(-phen)]·HO () [HL = -HO-CHC(H)=N-CH-SH-, -phen = 1,10-phenanthroline] was structurally characterized using single-crystal X-ray crystallography. in CHCN at liquid nitrogen temperature displayed a characteristic monomeric X-band electron paramagnetic resonance spectrum having a tetragonal character with = 2.1479 and = 2.0691 and ≈ 18.0 mT and ≤ 3.9 mT, respectively. showed a strong binding affinity toward calf thymus DNA as reflected from its intrinsic binding constant ( = 7.88 × 10 M), and its competitive displacement of ethidium bromide suggested an intercalative DNA-binding mode ( = 1.32 × 10 M). This was confirmed from the viscosity study that showed an increase in the viscosity of DNA with an increasing concentration of . Complex is highly efficient in promoting oxidative and hydrolytic DNA cleavage ( = 1.987 h). showed a strong binding affinity with the carrier protein human serum albumin (HSA) ( = 5.22 × 10 M). A high bimolecular quenching constant = 2.29 × 10 Ms indicated a static quenching mechanism involved in the fluorescence quenching of HSA by . Fluorescence resonance energy transfer theory suggested that the distance ( = 3.52 nm) between and HSA is very close. Molecular docking studies suggested that primarily binds to HSA in subdomain IIA. A protein-ligand interaction profiler was used to visualize hydrophobic, hydrogen bonds, and π-cation interactions between HSA and . A 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay using HeLa and MDA-MB-231 cells showed a significant in vitro anticancer activity of (IC 2.63 and 2.68 μM, respectively). Nuclear staining assays suggested apoptotic cell death in HeLa cells treated with . The effect of on the cytoskeletal actin filaments visualized using phalloidin staining showed extensive destruction of actin filaments. Flow cytometric analysis indicated that inhibits the growth of HeLa cells through cell cycle arrest in the S phase. Western blot analysis showed upregulation in the expression of apoptotic marker proteins caspase 3, p53, and Bax. These results collectively indicate that induces apoptosis by promoting DNA damage and has a high potential to act as an anticancer agent.

Anticancer activity and biophysical reactivity of copper complexes of 2-(benzo[d][1,3]dioxol-5-ylmethylene)-N-alkylhydrazinecarbothioamides

Synthesis, characterization and biological activity of novel copper complexes containing a β-carboline derivative and amino acids

Synthesis, Characterization, DNA/HSA Interactions, and Anticancer Activity of Two Novel Copper(II) Complexes with 4-Chloro-3-Nitrobenzoic Acid Ligand

Copper(II) complexes incorporated with 2,2-bipyridyl and 2,2′-(((1E,1′E)-1,4-phenylene-bis(methanylylidene))bis(azanylylidene)) diphenol derivatives: In-vitro interaction with DNA/BSA, DFT, molecular docking and cytotoxicity

1‐Benzyl‐1H‐indazol‐3‐ol Copper(II) Derivatives as Anticancer Agents: In‐vitro Interaction with DNA/BSA, DFT, Molecular Docking and Cytotoxicity on MCF7 Cells

Synthesis And Structure Of New Dicopper(Ii) Complexes Bridged By Asymmetric N, N '-Bis( Substituted) Oxamides: In Vitro Anticancer Activity And Molecular Docking Studies Based On Bio-Macromolecular Interaction

Syntheses and Crystal Structures of Tetracopper(Ii) Complexes Bridged by Asymmetric N,N '-Bis(substituted)oxamides: Molecular Docking, Dna-Binding and in Vitro Anticancer Activity

Antitumor copper(II) complexes with hydroxyanthraquinones and N,N-heterocyclic ligands

Synthesis and Structure of Dicopper(Ii) Complexes Bridged by N-(5-Chloro-2-Hydroxyphenyl)-N '[3-(Methy Lamino)Propyl]Oxamide: Evaluation of Dna/Protein Binding, Dna Cleavage, and in Vitro Anticancer Activity

DNA Binding and in Vitro Anticarcinogenic Activity of a Series of Newfashioned Cu(II)-complexes Based on Tricationic Metalloporphyrin Salicyloylhydrazone Ligands.

Synthesis, structural studies, interaction with DNA/HSA and antitumor evaluation of new Cu(II) complexes containing 2-(1H-imidazol-2-yl)pyridine and amino acids

Biological and cytoselective anticancer properties of copper(II)-polypyridyl complexes modulated by auxiliary methylated glycine ligand

Mixed Ligand Mononuclear Copper(II) Complex as a Promising Anticancer Agent: Interaction Studies with DNA/HSA, Molecular Docking, and In Vitro Cytotoxicity Studies.

Synthesis, Antiproliferative Activity and Mechanism of Copper(ii)-Thiosemicarbazone Complexes As Potential Anticancer and Antimicrobial Agents

Antiproliferative Activity of Platinum(II) and Copper(II) Complexes Containing Novel Biquinoxaline Ligands

Anti-Cancer Activities and DNA/BSA Interactions for Five Cu(II) Compounds with Substituted Terpyridine Ligands

Synthesis and Structure of New Dicopper(Ii) Complexes Bridged by N-(2-Hydroxy-5-Methylphenyl)-N '-[3-(dimethylamino)propyl]oxamide with in Vitro Anticancer Activity: A Comparative Study of Reactivities Towards Dna/Protein by Molecular Docking and Experimental Assays

Synthesis and structure of a new tetracopper(II) complex with N -benzoate- N′ -[2-(2-hydroxyethylamino)ethyl]oxamide as bridging ligand: In vitro anticancer activities and DNA- and BSA-binding studies

Copper(II) complexes containing hydrazone and bipyridine/phenanthroline ligands for anticancer application against breast cancer cells

Four Cu(ii) complexes based on antitumor chelators: synthesis, structure, DNA binding/damage, HSA interaction and enhanced cytotoxicity

Functional copper complexes with benzofurans tridentate ligand: Synthesis, crystal structure, DNA binding and anticancer studies